Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis
about
False Discovery Rates in PET and CT Studies with Texture Features: A Systematic ReviewTumour Cell HeterogeneityRethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancerHarnessing Pandemonium: The Clinical Implications of Tumor Heterogeneity in Ovarian CancerMolecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and TreatmentUpdate on immune checkpoint inhibitors in gynecological cancersFive selfish reasons to work reproduciblyUnravelling tumour heterogeneity using next-generation imaging: radiomics, radiogenomics, and habitat imaging.A Strategy to Delay the Development of Cisplatin Resistance by Maintaining a Certain Amount of Cisplatin-Sensitive Cells.Distinct implications of different BRCA mutations: efficacy of cytotoxic chemotherapy, PARP inhibition and clinical outcome in ovarian cancerPhylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrationsUse and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer.Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma-experience of the BriTROC consortium.Epithelial-to-Mesenchymal Transition in the Female Reproductive Tract: From Normal Functioning to Disease Pathology.You Are Not Working for Me; I Am Working with You.APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity.Intra-Gene DNA Methylation Variability Is a Clinically Independent Prognostic Marker in Women's Cancers.Modeling the Dynamics of High-Grade Serous Ovarian Cancer Progression for Transvaginal Ultrasound-Based Screening and Early DetectionNext-Generation Sequencing to Guide Clinical Trials.Mechanisms and Targets Involved in Dissemination of Ovarian Cancer.Tumor Evolution in Two Patients with Basal-like Breast Cancer: A Retrospective Genomics Study of Multiple MetastasesExploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective StudyAll biology is computational biology.Addressing challenges of heterogeneous tumor treatment through bispecific protein-mediated pretargeted drug delivery.Quantification of within-sample genetic heterogeneity from SNP-array data.Characterizing optical properties and spatial heterogeneity of human ovarian tissue using spatial frequency domain imaging.Turning the headlights on novel cancer biomarkers: Inspection of mechanics underlying intratumor heterogeneityMassively Parallel Sequencing-Based Clonality Analysis of Synchronous Endometrioid Endometrial and Ovarian Carcinomas.Mathematical models of breast and ovarian cancers.Genetic and molecular changes in ovarian cancer.Xenopatients show the need for precision medicine approach to chemotherapy in ovarian cancer.Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma.Haploinsufficiency networks identify targetable patterns of allelic deficiency in low mutation ovarian cancer.Homologous recombination deficiency (HRD) testing in ovarian cancer clinical practice: a review of the literature.Targeting the folate receptor: diagnostic and therapeutic approaches to personalize cancer treatments.Inferring the Origin of Metastases from Cancer Phylogenies.Spatial and temporal epithelial ovarian cancer cell heterogeneity impacts Maraba virus oncolytic potential.Pathways to Genome-targeted Therapies in Serous Ovarian Cancer.CDK6 protects epithelial ovarian cancer from platinum-induced death via FOXO3 regulation.Evaluating optimal therapy robustness by virtual expansion of a sample population, with a case study in cancer immunotherapy.
P2860
Q24288664-1EA7D2A4-30F1-4648-BB11-D02FC98EF565Q26765895-FAA9B8F1-6CEF-43B8-A01D-61608C2E4DBDQ26780387-93B483CF-2542-4A09-A428-DE5A61D4A9ACQ26801525-43F0AB7C-28C7-4E1F-8CB0-DFF2F575C21AQ28066904-AC19657C-CB6B-43CF-83A6-E001ABEAFB1EQ28076497-48B903AB-C8DB-42C8-BCA1-28CE7948A8E8Q28606547-6F480016-8163-4B70-ABC7-385CBF9BAF92Q30394115-5A564EA5-59E6-45E1-96AE-10EAF20C3D76Q33671792-7ED28FB2-B7A3-4B52-973C-32CC3F6C7F7EQ33704050-CA41168B-8593-4A65-9DFA-427F1F13BDBBQ33810500-E77C07DC-EF90-46AB-9D9E-7507674384B1Q33816983-DF28A171-1847-4B16-B40E-861AE0A4F2F5Q33829756-636059A1-0754-4FEC-9C80-130765BD1CD3Q33872622-7952D320-2F61-4ACB-90A9-22F10F53056FQ35786541-211109FA-71FD-4C56-9DDB-74045FD22230Q35836909-7F94EA3D-53AD-4C34-B755-9E1EA1A87722Q35858677-A1C47362-12C9-4786-9BBE-9368ED7CA3ABQ36039369-65031362-3751-46BE-8806-3BC60BE6E818Q36174832-6A8FC209-F96D-4F65-A1CC-8849E6E5A6BBQ36180735-7AC9CAD9-2C08-4D56-81C0-4763E913743EQ36214193-6ADB8EE8-F6C4-4163-8E9F-39E6DD7AD7BAQ36229421-1610EDE4-E81E-4A45-ACC4-C8683AA42144Q36302184-192290D0-BF22-45E2-8B10-8E8B75EB2C4DQ36395999-AB2646D3-8C98-46D1-9087-30B24E78F104Q36399981-57CA57CE-C2EE-4899-BAC4-1278EAF3AC4DQ36507803-D994E1E3-F299-46A9-9694-6293ED44B16DQ36658298-32BEA92F-4F46-4C4B-A5CB-1FF021EF40C2Q37007851-29E4CA0B-BBC3-4AB6-A7E6-30B043C1CC8FQ37014152-80FEA79A-522A-437B-8912-A9888E80C691Q37094076-1A4F7B06-C062-4310-B385-058BA8C34C1FQ37295618-1EE45A71-0282-4CEA-A787-7D4F6492F7CEQ37388203-D35AA57F-8DB3-498D-9B2E-BBBAFA891323Q37651932-0AAF0653-3866-4DAB-84CA-9B52BEBA08BDQ37661436-4DCB6A76-718E-44F0-9050-9504BFB9AE3BQ38524502-7EE26332-49CB-458A-A7A1-05FA882BC6B4Q38564005-C7978F0A-58CD-427C-92E8-7FB65001D80FQ38601861-D48EBE1B-81EB-4EA8-9E38-2C870A38D900Q38621094-63CA677E-29B9-4DAF-80D6-BBBC4CAD3C38Q38639827-35055B37-ACE4-46C5-9965-3E366CEFA981Q38674852-A928758A-E32F-46AD-998D-33B91443FFEE
P2860
Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Spatial and temporal heterogen ...... ancer: a phylogenetic analysis
@ast
Spatial and temporal heterogen ...... ancer: a phylogenetic analysis
@en
Spatial and temporal heterogen ...... ancer: a phylogenetic analysis
@nl
type
label
Spatial and temporal heterogen ...... ancer: a phylogenetic analysis
@ast
Spatial and temporal heterogen ...... ancer: a phylogenetic analysis
@en
Spatial and temporal heterogen ...... ancer: a phylogenetic analysis
@nl
prefLabel
Spatial and temporal heterogen ...... ancer: a phylogenetic analysis
@ast
Spatial and temporal heterogen ...... ancer: a phylogenetic analysis
@en
Spatial and temporal heterogen ...... ancer: a phylogenetic analysis
@nl
P2093
P2860
P50
P3181
P1433
P1476
Spatial and temporal heterogen ...... ancer: a phylogenetic analysis
@en
P2093
Anna M Piskorz
Christine A Parkinson
Davina Gale
Jillian Temple
Karen Sayal
Mercedes Jimenez-Linan
Muhammed Murtaza
Nitzan Rosenfeld
Peter J Baldwin
P2860
P304
P3181
P356
10.1371/JOURNAL.PMED.1001789
P407
P577
2015-02-01T00:00:00Z